These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35446292)

  • 21. Exercise-based cardiac rehabilitation for chronic heart failure: the EXTRAMATCH II individual participant data meta-analysis.
    Taylor RS; Walker S; Ciani O; Warren F; Smart NA; Piepoli M; Davos CH
    Health Technol Assess; 2019 May; 23(25):1-98. PubMed ID: 31140973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of nursing intervention based on a positive motivational model on cardiac function, self-management and quality of life in elderly patients with coronary heart disease.
    Tuo Ya SR; Lei YY; Bao LX; Cui XS
    Eur Rev Med Pharmacol Sci; 2023 Sep; 27(17):7977-7987. PubMed ID: 37750626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exercise-based cardiac rehabilitation in patients with reduced left ventricular ejection fraction: The Cardiac Rehabilitation Outcome Study in Heart Failure (CROS-HF): A systematic review and meta-analysis.
    Bjarnason-Wehrens B; Nebel R; Jensen K; Hackbusch M; Grilli M; Gielen S; Schwaab B; Rauch B;
    Eur J Prev Cardiol; 2020 Jun; 27(9):929-952. PubMed ID: 31177833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and efficacy of direct Cardiac Shockwave Therapy in patients with ischemic cardiomyopathy undergoing coronary artery bypass grafting (the CAST-HF trial): study protocol for a randomized controlled trial.
    Pölzl L; Nägele F; Graber M; Hirsch J; Lobenwein D; Mitrovic M; Mayr A; Theurl M; Schreinlechner M; Pamminger M; Dorfmüller C; Grimm M; Gollmann-Tepeköylü C; Holfeld J
    Trials; 2020 May; 21(1):447. PubMed ID: 32473644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction: Rationale and Design of GALACTIC-HF.
    Teerlink JR; Diaz R; Felker GM; McMurray JJV; Metra M; Solomon SD; Legg JC; Büchele G; Varin C; Kurtz CE; Malik FI; Honarpour N
    JACC Heart Fail; 2020 Apr; 8(4):329-340. PubMed ID: 32035892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of early exercise on cardiac rehabilitation-related outcome in acute heart failure patients: A systematic review and meta-analysis.
    Meng Y; Zhuge W; Huang H; Zhang T; Ge X
    Int J Nurs Stud; 2022 Jun; 130():104237. PubMed ID: 35421772
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design of a multicentre randomized controlled trial to assess the safety and efficacy of dose titration by specialized nurses in patients with heart failure. ETIFIC study protocol.
    Oyanguren J; García-Garrido L; Nebot Margalef M; Lekuona I; Comin-Colet J; Manito N; Roure J; Ruiz Rodriguez P; Enjuanes C; Latorre P; Torcal Laguna J; García-Gutiérrez S;
    ESC Heart Fail; 2017 Nov; 4(4):507-519. PubMed ID: 29154427
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial.
    Jorsal A; Kistorp C; Holmager P; Tougaard RS; Nielsen R; Hänselmann A; Nilsson B; Møller JE; Hjort J; Rasmussen J; Boesgaard TW; Schou M; Videbaek L; Gustafsson I; Flyvbjerg A; Wiggers H; Tarnow L
    Eur J Heart Fail; 2017 Jan; 19(1):69-77. PubMed ID: 27790809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Exploration on the Value of Circulation Quality Control Intervention Mode in Percutaneous Coronary Intervention in Patients with Coronary Heart Disease and Chronic Heart Failure.
    Yang X; Ren S; Liu Y; Wu X; Hao X; Bai X; Li R
    Heart Surg Forum; 2023 Dec; 26(6):E889-E895. PubMed ID: 38178330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of levothyroxine (L-T4) replacement on the exercise capability in chronic systolic heart failure patients with subclinical hypothyroidism: Study protocol for a multi-center, open label, randomized, parallel group trial (ThyroHeart-CHF).
    Zhang X; Wang WY; Zhang K; Tian J; Zheng JL; Chen J; An SM; Wang SY; Liu YP; Zhao Y; Wang JJ; Yang M; Tang YD
    Trials; 2019 Feb; 20(1):143. PubMed ID: 30782213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of 6-min walk test with left ventricular function and quality of life in heart failure due to Chagas disease.
    Chambela MC; Mediano MFF; Ferreira RR; Japiassú AM; Waghabi MC; da Silva GMS; Saraiva RM
    Trop Med Int Health; 2017 Oct; 22(10):1314-1321. PubMed ID: 28805026
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Yoga and breathing technique training in patients with heart failure and preserved ejection fraction: study protocol for a randomized clinical trial.
    Lopes CP; Danzmann LC; Moraes RS; Vieira PJC; Meurer FF; Soares DS; Chiappa G; Guimarâes LSP; Leitão SAT; Ribeiro JP; Biolo A
    Trials; 2018 Jul; 19(1):405. PubMed ID: 30055633
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of mineralocorticoid receptor antagonists on cardiac function in patients with heart failure and preserved ejection fraction: a systematic review and meta-analysis of randomized controlled trials.
    Kapelios CJ; Murrow JR; Nührenberg TG; Montoro Lopez MN
    Heart Fail Rev; 2019 May; 24(3):367-377. PubMed ID: 30618017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical assessment of complementary treatment with Qishen Yiqi dripping pills on ischemic heart failure: study protocol for a randomized, double-blind, multicenter, placebo-controlled trial (CACT-IHF).
    Hou YZ; Wang S; Zhao ZQ; Wang XL; Li B; Soh SB; Mao JY
    Trials; 2013 May; 14():138. PubMed ID: 23672353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Assessment of Complementary Treatment with Yiqi Fumai Lyophilized Injection on Acute Decompensated Ischemic Heart Failure (ACT-ADIHF): Rationale and Design of a Multicenter, Randomized, Controlled Trial.
    Wang X; Zhao Z; Hou Y; Tang E; Zhao G; Wang S; Bi Y; Zhong C; Ren M; Zhang J; Mao J; Zhang B
    Cardiovasc Drugs Ther; 2018 Jun; 32(3):295-300. PubMed ID: 29713851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of ivabradine on the cardiac function of chronic heart failure reduced ejection fraction: Meta-analysis of randomized controlled trials.
    Bryan Richard S; Huang B; Liu G; Yang Y; Luo S
    Clin Cardiol; 2021 Apr; 44(4):463-471. PubMed ID: 33638556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ivabradine Improves Cardiac Function and Increases Exercise Capacity in Patients with Chronic Heart Failure.
    Pei H; Miao W; Xie WZ; Wang W; Zhao D; Su GH; Zhao Z
    Int Heart J; 2019 Jul; 60(4):899-909. PubMed ID: 31308326
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tongmai Yangxin intervening in myocardial remodeling after PCI for coronary heart disease: study protocol for a double-blind, randomized controlled trial.
    Wang Y; Wang X; Wang J; Li B; Yu R; Hu Y; Li X; Peng G; Zhang M; Zhu M
    Trials; 2020 Mar; 21(1):287. PubMed ID: 32197640
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of left bundle branch area pacing versus biventricular pacing in heart failure patients with left bundle branch block: study protocol for a randomised controlled trial.
    Cheng L; Zhang J; Wang Z; Zhou M; Liang Z; Zhao L; Chen J; Wu Y
    BMJ Open; 2020 Sep; 10(9):e036972. PubMed ID: 32973057
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.